Ingalls & Snyder LLC’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $7.57M | Sell |
|
|||||
|
2022
Q3 | $8.91M | Sell |
|
|||||
|
2022
Q2 | $5.94M | Buy |
|
|||||
|
2022
Q1 | $4.44M | Sell |
|
|||||
|
2021
Q4 | $4.28M | Sell |
|
|||||
|
2021
Q3 | $5.73M | Buy |
|
|||||
|
2021
Q2 | $7.3M | Buy |
|
|||||
|
2021
Q1 | $7.25M | Buy |
|
|||||
|
2020
Q4 | $17.2M | Sell |
|
|||||
|
2020
Q3 | $13.4M | Sell |
|
|||||
|
2020
Q2 | $13.8M | Sell |
|
|||||
|
2020
Q1 | $12.9M | Sell |
|
|||||
|
2019
Q4 | $13.5M | Sell |
|
|||||
|
2019
Q3 | $9.01M | Buy |
|
|||||
|
2019
Q2 | $16.3M | Buy |
|
|||||
|
2019
Q1 | $14.2M | Sell |
|
|||||
|
2018
Q4 | $14.8M | Sell |
|
|||||
|
2018
Q3 | $19.9M | Buy |
|
|||||
|
2018
Q2 | $22.5M | Buy |
|
|||||
|
2018
Q1 | $30.3M | Buy |
|
|||||
|
2017
Q4 | $34M | Buy |
|
|||||
|
2017
Q3 | $17.8M | Buy |
|
|||||
|
2017
Q2 | $14.7M | Hold |
|
|||||
|
2017
Q1 | $18M | Sell |
|
|||||
|
2016
Q4 | $11M | Buy |
|
|||||
|
2016
Q3 | $9.04M | Buy |
|
|||||
|
2016
Q2 | $7.01M | Buy |
|
|||||
|
2016
Q1 | $4.35M | Sell |
|
|||||
|
2015
Q4 | $7.01M | Sell |
|
|||||
|
2015
Q3 | $6.95M | Buy |
|
|||||
|
2015
Q2 | $5.49M | Hold |
|
|||||
|
2015
Q1 | $5.58M | Buy |
|
|||||
|
2014
Q4 | $4.67M | Buy |
|